Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux

SC Wall, H Gu and G Rudnick

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.

LLC-PK1 cells have been stably transfected with cDNAs encoding the human norepinephrine transporter (NET), rat dopamine transporter (DAT), and rat serotonin transporter. Using these cell lines, the specificity of each transporter toward agents that inhibit substrate influx and stimulate substrate efflux across the plasma membrane was examined. With 1-methyl-4-phenylpyridinium as a substrate for DAT and NET and serotonin as a substrate for the serotonin transporter, each transporter demonstrated a distinct pattern of inhibition by a panel of amphetamine derivatives and analogs, including amphetamine, methamphetamine (also known as "ecstasy"), p-chloroamphetamine, 3,4- methylenedioxymethamphetamine, methylphenidate (ritalin), and 5-methoxy- 6-methyl-2-aminoindan. For each cell line expressing a single biogenic amine transporter, efflux of the accumulated substrate was stimulated by amphetamine derivatives, and this efflux was blocked by mazindol, an inhibitor of all three transporters. Of the amphetamine derivatives tested, some caused efflux at concentrations similar to those that inhibited transport. Other derivatives were much less effective at stimulating efflux than at inhibiting uptake. Methylphenidate caused little or no efflux, although it blocked uptake mediated by both NET and DAT. Other inhibitors of transport, such as cocaine, mazindol, citalopram, and nisoxetine, failed to stimulate efflux from these cells at concentrations that inhibited influx. The results suggest that potency toward individual plasma membrane biogenic amine transporters and the ability to release accumulated amine substrates are independent properties of each amphetamine derivative.

Volume 47, Issue 3, pp. 544-550, 03/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				Z. Xie and G. M. Miller Trace Amine-Associated Receptor 1 Is a Modulator of the Dopamine Transporter J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 128 - 136. [Abstract] [Full Text] [PDF]

				C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes Mol. Pharmacol., January 1, 2007; 71(1): 230 - 239. [Abstract] [Full Text] [PDF]

				Y.-W. Zhang and G. Rudnick Cysteine-scanning Mutagenesis of Serotonin Transporter Intracellular Loop 2 Suggests an {alpha}-Helical Conformation J. Biol. Chem., September 2, 2005; 280(35): 30807 - 30813. [Abstract] [Full Text] [PDF]

				C. Pifl, G. Nagy, S. Berenyi, A. Kattinger, H. Reither, and S. Antus Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 346 - 354. [Abstract] [Full Text] [PDF]

				D. G. Smith, E. T. Tzavara, J. Shaw, S. Luecke, M. Wade, R. Davis, C. Salhoff, G. G. Nomikos, and D. R. Gehlert Mesolimbic Dopamine Super-Sensitivity in Melanin-Concentrating Hormone-1 Receptor-Deficient Mice J. Neurosci., January 26, 2005; 25(4): 914 - 922. [Abstract] [Full Text] [PDF]

				L. Kantor, M. Zhang, B. Guptaroy, Y. H. Park, and M. E. Gnegy Repeated Amphetamine Couples Norepinephrine Transporter and Calcium Channel Activities in PC12 Cells J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1044 - 1051. [Abstract] [Full Text] [PDF]

				A.-K. Meinild, H. H. Sitte, and U. Gether Zinc Potentiates an Uncoupled Anion Conductance Associated with the Dopamine Transporter J. Biol. Chem., November 26, 2004; 279(48): 49671 - 49679. [Abstract] [Full Text] [PDF]

				Y. Sato, Y.-W. Zhang, A. Androutsellis-Theotokis, and G. Rudnick Analysis of Transmembrane Domain 2 of Rat Serotonin Transporter by Cysteine Scanning Mutagenesis J. Biol. Chem., May 28, 2004; 279(22): 22926 - 22933. [Abstract] [Full Text] [PDF]

				D. L. Roman, S. N. Saldana, D. E. Nichols, F. I. Carroll, and E. L. Barker Distinct Molecular Recognition of Psychostimulants by Human and Drosophila Serotonin Transporters J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 679 - 687. [Abstract] [Full Text] [PDF]

				G. J. Rodriguez, D. L. Roman, K. J. White, D. E. Nichols, and E. L. Barker Distinct Recognition of Substrates by the Human and Drosophila Serotonin Transporters J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 338 - 346. [Abstract] [Full Text] [PDF]

				A. Androutsellis-Theotokis, N. R. Goldberg, K. Ueda, T. Beppu, M. L. Beckman, S. Das, J. A. Javitch, and G. Rudnick Characterization of a Functional Bacterial Homologue of Sodium-dependent Neurotransmitter Transporters J. Biol. Chem., April 4, 2003; 278(15): 12703 - 12709. [Abstract] [Full Text] [PDF]

				J. W. Schwartz, R. D. Blakely, and L. J. DeFelice Binding and Transport in Norepinephrine Transporters. REAL-TIME, SPATIALLY RESOLVED ANALYSIS IN SINGLE CELLS USING A FLUORESCENT SUBSTRATE J. Biol. Chem., March 7, 2003; 278(11): 9768 - 9777. [Abstract] [Full Text] [PDF]

				U. Sung, S. Apparsundaram, A. Galli, K. M. Kahlig, V. Savchenko, S. Schroeter, M. W. Quick, and R. D. Blakely A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity J. Neurosci., March 1, 2003; 23(5): 1697 - 1709. [Abstract] [Full Text] [PDF]

				M. H. Baumann, M. A. Ayestas, L. G. Sharpe, D. B. Lewis, K. C. Rice, and R. B. Rothman Persistent Antagonism of Methamphetamine-Induced Dopamine Release in Rats Pretreated with GBR12909 Decanoate J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1190 - 1197. [Abstract] [Full Text] [PDF]

				I. S. Ramsey and L. J. DeFelice Serotonin Transporter Function and Pharmacology Are Sensitive to Expression Level. EVIDENCE FOR AN ENDOGENOUS REGULATORY FACTOR J. Biol. Chem., April 19, 2002; 277(17): 14475 - 14482. [Abstract] [Full Text] [PDF]

				M. Rozans, A. Dreisbach, J. J.L. Lertora, and M. J. Kahn Palliative Uses of Methylphenidate in Patients With Cancer: A Review J. Clin. Oncol., January 1, 2002; 20(1): 335 - 339. [Abstract] [Full Text] [PDF]

				H. H. Sitte, B. Hiptmair, J. Zwach, C. Pifl, E. A. Singer, and P. Scholze Quantitative Analysis of Inward and Outward Transport Rates in Cells Stably Expressing the Cloned Human Serotonin Transporter: Inconsistencies with the Hypothesis of Facilitated Exchange Diffusion Mol. Pharmacol., April 16, 2001; 59(5): 1129 - 1137. [Abstract] [Full Text]

				P. Scholze, J. Zwach, A. Kattinger, C. Pifl, E. A. Singer, and H. H. Sitte Transporter-Mediated Release: A Superfusion Study on Human Embryonic Kidney Cells Stably Expressing the Human Serotonin Transporter J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 870 - 878. [Abstract] [Full Text]

				N. C. E. Smith and R. Levi LLC-PK1 Cells Stably Expressing the Human Norepinephrine Transporter: A Functional Model of Carrier-Mediated Norepinephrine Release in Protracted Myocardial Ischemia J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 456 - 463. [Abstract] [Full Text]

				C. Pifl and E. A. Singer Ion Dependence of Carrier-Mediated Release in Dopamine or Norepinephrine Transporter-Transfected Cells Questions the Hypothesis of Facilitated Exchange Diffusion Mol. Pharmacol., November 1, 1999; 56(5): 1047 - 1054. [Abstract] [Full Text]

				D. S. Segal and R. Kuczenski Escalating Dose-Binge Treatment with Methylphenidate: Role of Serotonin in the Emergent Behavioral Profile J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 19 - 30. [Abstract] [Full Text]

				R. B. Rothman, M. A. Ayestas, C. M. Dersch, and M. H. Baumann Aminorex, Fenfluramine, and Chlorphentermine Are Serotonin Transporter Substrates : Implications for Primary Pulmonary Hypertension Circulation, August 24, 1999; 100(8): 869 - 875. [Abstract] [Full Text] [PDF]

				J. K. Weatherspoon and L. L. Werling Modulation of Amphetamine-Stimulated [3H]Dopamine Release from Rat Pheochromocytoma (PC12) Cells by sigma  Type 2 Receptors J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 278 - 284. [Abstract] [Full Text]

				A. Galli, R. D. Blakely, and L. J. DeFelice Patch-clamp and amperometric recordings from norepinephrine transporters: Channel activity and voltage-dependent uptake PNAS, October 27, 1998; 95(22): 13260 - 13265. [Abstract] [Full Text] [PDF]

				J.-G. Chen, S. Liu-Chen, and G. Rudnick Determination of External Loop Topology in the Serotonin Transporter by Site-directed Chemical Labeling J. Biol. Chem., May 15, 1998; 273(20): 12675 - 12681. [Abstract] [Full Text] [PDF]

				J.-G. Chen, A. Sachpatzidis, and G. Rudnick The Third Transmembrane Domain of the Serotonin Transporter Contains Residues Associated with Substrate and Cocaine Binding J. Biol. Chem., November 7, 1997; 272(45): 28321 - 28327. [Abstract] [Full Text] [PDF]

				M. S. Sonders, S.-J. Zhu, N. R. Zahniser, M. P. Kavanaugh, and S. G. Amara Multiple Ionic Conductances of the Human Dopamine Transporter: The Actions of Dopamine and Psychostimulants J. Neurosci., February 1, 1997; 17(3): 960 - 974. [Abstract] [Full Text] [PDF]

				F. J.S. Lee, Z. B. Pristupa, B. J. Ciliax, A. I. Levey, and H. B. Niznik The Dopamine Transporter Carboxyl-terminal Tail. TRUNCATION/SUBSTITUTION MUTANTS SELECTIVELY CONFER HIGH AFFINITY DOPAMINE UPTAKE WHILE ATTENUATING RECOGNITION OF THE LIGAND BINDING DOMAIN J. Biol. Chem., August 23, 1996; 271(34): 20885 - 20894. [Abstract] [Full Text] [PDF]

				Y. Liu, C. Waites, D. Krantz, P. Tan, and R.H. Edwards Molecular Analysis of Neurotransmitter Transport into Secretory Vesicles Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 747 - 758. [Abstract] [PDF]